Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Publication of AR132160A2publicationCriticalpatent/AR132160A2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
La presente invención se relaciona con una formulación farmacéutica acuosa que comprende 1-(4-{[4-(dimetilamino)piperidin-1-il]carbonil}enil)-3-[4-(4,6-dimorfolin-4-il-1,3,5-triazin-2-il)enil]urea, o una sal farmacéuticamente aceptable de la misma, que es una solución transparente. Tal formulación es particularmente adecuada para administración intravenosa o parenteral a un paciente.The present invention relates to an aqueous pharmaceutical formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}enyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)enyl]urea, or a pharmaceutically acceptable salt thereof, which is a clear solution. Such a formulation is particularly suitable for intravenous or parenteral administration to a patient.
ARP240100661A2014-12-172024-03-18
PHARMACEUTICAL COMPOSITION IN AQUEOUS SOLUTION
AR132160A2
(en)